Clinical Microbiomics accelerates expansion with €10m investment

Clinical Microbiomics accelerates expansion with €10m investment

Clinical Microbiomics partners innovators in microbiome research across the pharma/biotech, consumer health, and academic spaces, becoming particularly known for its pioneering work on clonal-level microbiome profiling that is recognised as the most sensitive, precise, and comprehensive in the field.

Importantly, the seven-year-old company hosts the richest data-warehouse on the market with more than 30,000 samples linking more than 3 million bacterial strains to clinical phenotypes. 

The investment, from Seventure’s Health for Life Capital II fund, will be used to further advance the company’s microbiome profiling and systems biology platform, and to expand the service offering within multi-omics data integration, as well as to build further presence across other key global markets starting with the US.

“Our vision is a world where people are healthier because we understand how to improve our inner ecology – the microbiome,” ​says Anders Grøn, CEO at Clinical Microbiomics, “We challenge the idea that the complexity of the microbiome prevents us from exploring its potential to tackle the most pressing health questions of our time.

“Seventure Partners brings valuable experience across the microbiome field that will help us identify and address challenges across the sector, and their investment will enable us to expand our innovation programs, quality management systems, and strategic collaborations at a high pace to help researchers worldwide to bring new products and treatments to market.”

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *